Author
Listed:
- Supriya Ravichandran
(Center for Biologics Evaluation and Research (CBER), FDA)
- Megan Hahn
(Center for Biologics Evaluation and Research (CBER), FDA)
- Pablo F. Belaunzarán-Zamudio
(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
- José Ramos-Castañeda
(Instituto Nacional de Salud Publica)
- Gabriel Nájera-Cancino
(Hospital Regional de Alta Especialidad Ciudad Salud)
- Sandra Caballero-Sosa
(Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)
- Karla R. Navarro-Fuentes
(Instituto Mexicano del Seguro Social)
- Guillermo Ruiz-Palacios
(Comisión Coordinadora de los Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Ministry of Health)
- Hana Golding
(Center for Biologics Evaluation and Research (CBER), FDA)
- John H. Beigel
(Frederick National Laboratory for Cancer Research
National Institutes of Health)
- Surender Khurana
(Center for Biologics Evaluation and Research (CBER), FDA)
Abstract
Zika virus (ZIKV) outbreak in Americas led to extensive efforts to develop vaccines and ZIKV-specific diagnostics. In the current study, we use whole genome phage display library spanning the entire ZIKV genome (ZIKV-GFPDL) for in-depth immune profiling of IgG and IgM antibody repertoires in serum and urine longitudinal samples from individuals acutely infected with ZIKV. We observe a very diverse IgM immune repertoire encompassing the entire ZIKV polyprotein on day 0 in both serum and urine. ZIKV-specific IgG antibodies increase 10-fold between day 0 and day 7 in serum, but not in urine; these are highly focused on prM/E, NS1 and NS2B. Differential antibody affinity maturation is observed against ZIKV structural E protein compared with nonstructural protein NS1. Serum antibody affinity to ZIKV-E protein inversely correlates with ZIKV disease symptoms. Our study provides insight into unlinked evolution of immune response to ZIKV infection and identified unique targets for ZIKV serodiagnostics.
Suggested Citation
Supriya Ravichandran & Megan Hahn & Pablo F. Belaunzarán-Zamudio & José Ramos-Castañeda & Gabriel Nájera-Cancino & Sandra Caballero-Sosa & Karla R. Navarro-Fuentes & Guillermo Ruiz-Palacios & Hana Gol, 2019.
"Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09914-3
DOI: 10.1038/s41467-019-09914-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09914-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.